Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ESMO 2023 | How can ctDNA analysis guide treatment in cancer?

Klaus Pantel, MD, PhD, University Medical Centre Hamburg-Eppendorf, Hamburg, Germany, comments on the utility of circulating tumor DNA (ctDNA) in guiding treatment for patients. With the emergence of multiple technologies and techniques can sensitively detect ctDNA, cancer can be detected at earlier stages and relapses can be predicted if needed. This interview took place at the European Society for Medical Oncology (ESMO) 2023 Congress in Madrid, Spain.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.

Choose your cookie settings

VJOncology uses necessary cookies to make the site work. With your permission we'd also like to use analytics, preference and marketing cookies to understand how the site is used and improve it.

Choose an option to continue. You can change it at any time on our Cookie Policy page, linked at the bottom of every page.